4//SEC Filing
Wooldridge James 4
Accession 0001567619-19-005837
CIK 0001636282other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:09 PM ET
Size
5.5 KB
Accession
0001567619-19-005837
Insider Transaction Report
Form 4
Wooldridge James
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-02-28+50,200→ 50,200 totalExercise: $8.36Exp: 2029-02-27→ Common Stock (50,200 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 28, 2019, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001710641
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:09 PM ET
- Size
- 5.5 KB